Impaired endothelial responses in apparently healthy young people associated with subclinical variation in blood pressure and cardiovascular phenotype

American Journal of Hypertension

Volumn 25, Issue 1, 2012, Pages 46-53

  Lazdam, Merzaka ^a,b   Lewandowski, Adam J ^a,b   Kylintireas, Ilias ^c   Cunnington, Colin ^a   Diesch, Jonathan ^a   Francis, Jane ^b   Trevitt, Corinne ^a   Neubauer, Stefan ^a,b   Singhal, Atul ^d   Leeson, Paul ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

blood pressure; endothelium; hypertension; intima media thickness; left ventricular mass; pulse wave velocity; young adults

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; COMMON CAROTID ARTERY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED DILATATION; GROUPS BY AGE; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; VASOMOTOR REFLEX;

ADOLESCENT; ADULT; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; PHENOTYPE; RISK FACTORS; VASCULAR STIFFNESS; VASODILATION;

EID: 83655201341     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2011.176     Document Type: Article

References (38)

1. Donald AE, Charakida M, Falaschetti E, Lawlor DA, Halcox JP, Golding J, Hingorani AD, Smith GD, Deanfield JE. Determinants of vascular phenotype in a large childhood population: the Avon Longitudinal Study of Parents and Children (ALSPAC). Eur Heart J 2010; 31:1502-1510.
2. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Rönnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004; 110:2918-2923. (Pubitemid 39473618)
3. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-argininenitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94:1298-1303. (Pubitemid 26307256)
4. Mohler ER 3rd, O'Hare K, Darze ES, Townsend RR, Bridges CR Jr, Keane MG. Cardiovascular function in normotensive offspring of persons with essential hypertension and black race. J Clin Hypertens (Greenwich) 2007; 9:506-512.
5. Torrens C, Kelsall CJ, Hopkins LA, Anthony FW, Curzen NP, Hanson MA. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner. Hypertension 2009; 53:661-667.
6. Leeson CP, Kattenhorn M, Morley R, Lucas A, Deanfield JE. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001; 103:1264-1268. (Pubitemid 32221350)
7. Leeson P. Pediatric prevention of atherosclerosis: targeting early variation in vascular biology. Pediatrics 2007; 119:1204-1206. (Pubitemid 46871279)
8. Lazdam M, de la Horra A, Pitcher A, Mannie Z, Diesch J, Trevitt C, Kylintireas I, Contractor H, Singhal A, Lucas A, Neubauer S, Kharbanda R, Alp N, Kelly B, Leeson P. Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension 2010; 56:159-165.
9. Jayet PY, Rimoldi SF, Stuber T, Salmòn CS, Hutter D, Rexhaj E, Thalmann S, Schwab M, Turini P, Sartori-Cucchia C, Nicod P, Villena M, Allemann Y, Scherrer U, Sartori C. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 2010; 122:488-494.
10. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105:213-217. (Pubitemid 34084321)
11. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 2002; 416:337-339.
12. Halcox JP, Donald AE, Ellins E, Witte DR, Shipley MJ, Brunner EJ, Marmot MG, Deanfield JE. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009; 119:1005-1012.
13. Manios E, Tsivgoulis G, Koroboki E, Stamatelopoulos K, Papamichael C, Toumanidis S, Stamboulis E, Vemmos K, Zakopoulos N. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass. Stroke 2009; 40:1515-1518.
14. Devereux RB, de Simone G, Koren MJ, Roman MJ, Laragh JH. Left ventricular mass as a predictor of development of hypertension. Am J Hypertens 1991; 4: 603S-607S.
15. Mahoney LT, Schieken RM, Clarke WR, Lauer RM. Left ventricular mass and exercise responses predict future blood pressure. The Muscatine Study. Hypertension 1988; 12:206-213.
16. Thomas F, Benetos A, Ducimetière P, Bean K, Guize L. Determinants of left ventricular mass in a French male population. Blood Press 1999; 8:79-84. (Pubitemid 29359481)
17. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F. Mannheim intimamedia thickness consensus. Cerebrovasc Dis 2004; 18:346-349.
18. Sanada S, Node K, Minamino T, Takashima S, Ogai A, Asanuma H, Ogita H, Liao Y, Asakura M, Kim J, Hori M, Kitakaze M. Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats. Hypertension 2003; 41:963-967. (Pubitemid 36418473)
19. Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A. Is slower early growth beneficial for long-term cardiovascular health? Circulation 2004; 109:1108-1113. (Pubitemid 38332614)
20. Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009; 54: 919-950.
21. Leeson CP, Robinson M, Francis JM, Robson MD, Channon KM, Neubauer S, Wiesmann F. Cardiovascular magnetic resonance imaging for non-invasive assessment of vascular function: validation against ultrasound. J Cardiovasc Magn Reson 2006; 8:381-387. (Pubitemid 43355112)
22. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Keaney JF Jr, Keyes MJ, Levy D, Vasan RS, Benjamin EJ. Local shear stress and brachial artery flowmediated dilation: the Framingham Heart Study. Hypertension 2004; 44: 134-139. (Pubitemid 39014228)
23. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 2002; 39:750-755. (Pubitemid 34252869)
24. Petersen SE, Hudsmith LE, Robson MD, Doll HA, Francis JM, Wiesmann F, Jung BA, Hennig J, Watkins H, Neubauer S. Sex-specific characteristics of cardiac function, geometry, and mass in young adult elite athletes. J Magn Reson Imaging 2006; 24:297-303. (Pubitemid 44188554)
25. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113:657-663.
26. Clay S, Alfakih K, Radjenovic A, Jones T, Ridgway JP, Sinvananthan MU. Normal range of human left ventricular volumes and mass using steady state free precession MRI in the radial long axis orientation. MAGMA 2006; 19:41-45.
27. Jackson LV, Thalange NK, Cole TJ. Blood pressure centiles for Great Britain. Arch Dis Child 2007; 92:298-303. (Pubitemid 46535509)
28. Antoniades C, Mussa S, Shirodaria C, Lee J, Diesch J, Taggart DP, Channon KM, Leeson P. Relation of preoperative radial artery flow-mediated dilatation to nitric oxide bioavailability in radial artery grafts used in off-pump coronary artery bypass grafting. Am J Cardiol 2009; 103:216-220.
29. Antoniades C, Van-Assche T, Shirodaria C, Diesch J, Antonopoulos AS, Lee J, Cunnington C, Tousoulis D, Stefanadis C, Casadei B, Taggart D, Channon KM, Leeson P. Preoperative sCD40L levels predict risk of atrial fibrillation after offpump coronary artery bypass graft surgery. Circulation 2009; 120:S170-S176.
30. Perticone F, Maio R, Ceravolo R, Cosco C, Cloro C, Mattioli PL. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients. Circulation 1999; 99:1991-1996. (Pubitemid 29183896)
31. Lind L. Left ventricular mass is related to endothelium-dependent vasodilation in the forearm, but not in the brachial artery, in elderly subjects: the Prospective Investigation of the Vasculature in Uppsala Seniors study. J Hum Hypertens 2008; 22:767-773.
32. Hasegawa T, Boden-Albala B, Eguchi K, Jin Z, Sacco RL, Homma S, Di Tullio MR. Impaired flow-mediated vasodilatation is associated with increased left ventricular mass in a multiethnic population. The Northern Manhattan Study. Am J Hypertens 2010; 23:413-419.
33. Yeboah J, Crouse JR, Bluemke DA, Lima JA, Polak JF, Burke GL, Herrington DM. Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA). J Hum Hypertens 2011; 25:25-31.
34. Robinson MR, Scheuermann-Freestone M, Leeson P, Channon KM, Clarke K, Neubauer S, Wiesmann F. Uncomplicated obesity is associated with abnormal aortic function assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10:10.
35. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004; 109:IV31-IV46.
36. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC, Kass DA. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008; 117:2626-2636.
37. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998; 101:812-818. (Pubitemid 28096078)
38. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, Lehman BT, Fan S, Osypiuk E, Vita JA. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004; 109:613-619. (Pubitemid 38198868)